Direxion Daily S&P Biotech Bear 3X Shares ETF failed to generate decent yield & price growth over the past 90 months. I don’t foresee this fund generating positive growth in the near future, either.
April was one of the wildest months in recent history. The S&P 500 and Dow Jones wrapped up the third consecutive month in the red, marking the longest monthly losing streak since 2023. The Nasdaq ...
(LABD) Direxion Daily S&P Biotech Bear 3x Shares 18.15% (DRV) Direxion Daily Real Estate Bear 3X Shares 17.16% (WEBS) Direxion Daily Dow Jones Internet Bear 3X Shares 16.18% (UVXY) ProShares Ultra VIX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback